Menu

Staphylococcus aureus

At IBT Bioservices, we understand the critical need for effective interventions against Staphylococcus aureus infections. We specialize in comprehensive preclinical testing services aimed at assessing the safety and efficacy of potential treatments and vaccines against this versatile and often antibiotic-resistant bacterium.

Diseases

Skin and Soft Tissue Infections (SSTI’s), Pneumonia, and Bacteremia

Infects

Elderly, infants, athletes, and healthy humans

Symptoms

Skin lesions, joint pain, and potentially septicemia

Bacterial Characteristics

Staphylococcus aureus is a Gram-positive bacterium. Methicillin-resistant strains of this bacterium pose a significant risk due to their resistance to treatment, requiring urgent research and advancements in effective therapies.

Staphylococcus aureus, commonly referred to as “Staph,” is a significant pathogen responsible for a wide range of infections, including skin and soft tissue infections, bloodstream infections, and pneumonia. The emergence of antibiotic-resistant strains, such as Methicillin-resistant Staphylococcus aureus (MRSA), has further complicated treatment options, making it crucial to develop novel therapies to combat these infections.

At IBT, our expert team of scientists have deep expertise in biology of S. aureus and utilize state-of-the-art facilities and advanced methodologies to perform thorough in vitro and in vivo preclinical testing for Staphylococcus aureus.

Our Range of In Vivo Efficacy Models Include

Skin and Soft Tissue Infections

Pneumonia Infections

Systemic Infections

Contact us today to learn more about how our preclinical testing services can accelerate the development of promising treatments and vaccines for Staphylococcus aureus.

Our preclinical testing services for Staphylococcus aureus encompasses:

Animal Models

Our experienced researchers utilize appropriate animal models, such as mice or nonhuman primates, to mimic Staphylococcus aureus infections and assess the safety and efficacy of potential interventions. We closely monitor key parameters, including bacterial load, tissue inflammation, immune response, disease progression, and overall health, to evaluate the effectiveness of the tested treatments or vaccines. Our in vivo studies provide critical data on the intervention’s ability to control bacterial growth, reduce tissue damage, and enhance host immune responses.

Pharmacokinetic and Toxicology Studies

Understanding how potential interventions are absorbed, distributed, metabolized, and eliminated by the body is crucial. Our comprehensive pharmacokinetic studies provide valuable insights into the intervention’s behavior, bioavailability, and optimal dosage. Additionally, toxicology evaluations ensure the safety of the treatment or vaccine candidates, assessing potential adverse effects and determining the appropriate dosage range.

In Vitro Assays

Using advanced molecular and cellular techniques, we evaluate the efficacy of potential drugs and vaccines against Staphylococcus aureus. These studies help identify compounds that can effectively inhibit bacterial growth, disrupt virulence factors, or enhance host immune response. We help clients assess their therapeutic candidates and investigate the mechanisms of action of potential interventions, providing valuable insights into their ability to combat Staphylococcus aureus infections.

At IBT, we are dedicated to advancing the field of Staphylococcus aureus research and development through reliable and accurate in vitro and in vivo preclinical testing services. Our commitment to scientific excellence, ethical practices, and adherence to regulatory guidelines positions us as a trusted partner in the fight against this bacterial infection. We provide you with high quality data and documentation supportive of your regulatory filings.

REFRENCE NUMBER: 22050

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. 

REFRENCE NUMBER: 22050

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat. 

REFRENCE NUMBER: 22050

REFERENCES

Search
Generic filters

Choice Billing Address

×

You have no billing addresses.

Choice Shipping Address

×